COVID-19 Vaccine?

With the global COVID-19 case count reaching 20 million, Russia has approved a vaccine for the disease. There is, however, suspicion around the approval since the trials have yet to conclude the Phase 3 testing. To solidify the vaccine approval, Russian President Vladimir Putin, stated the vaccine is working “effectively enough”- far too vague for most medical professionals throughout the world. What does “effectively enough” constitute? With the vaccination trials being rushed already through the world, how many corners are being cut by the nations at the head of the vaccination development? Like many questions that hint toward political gains and propaganda, we may never truly know the answer to how many corners are being cut on a vaccination approval that could indeed affect the entire globe for better or worse.

Russia has proceeded to approve the vaccination despite the World Health Organization’s best advice to stay true to the clinical trial methodology. Putin has stated that one of his children did receive the vaccination.

It is worth noting that the clinical trials include testing in 3 phases. Phase 1 and 2 are conducted with relatively small groupings, while the third phase can include tens of thousands of participants in a highly controlled and regulated study. During phase 3, there is a great opportunity, with such a large participation pool, to truly understand the placebo effect as compared to the actual vaccination. For a reference point, the U.S. FDA would require 50% or bett

 

er efficacy during phase 3 studies to pass on to the next phase. To be clear, that is 50% more effective than a placebo, which is by the very nature of the name, nothing.   This begs the question, with how strict the U.S. is perceived for clinical trials, how strict is Russia?   Being the 1st to the trough is not key in this COVID-19 world, it is the 1st to the trough with efficacy.

https://www.fda.gov/patients/drug-development-process/step-3-clinical-research

https://www.theverge.com/2020/8/11/21363135/russia-coronavirus-vaccine-unproven-registration

https://www.nytimes.com/2020/08/11/world/coronavirus-covid-19.html

 

Written by:

I am a proud Guttman Energy sales representative, who has a thirst of knowledge for the industry. I come from a strict, service based, industry that allows me to put my customer needs first. I look forward to utilizing my passion and past experience to help bolster my client’s operations. I take a personal pride in anything I do.

Guttman Energy Daily Market Update Disclaimer – The information contained in this market update is derived from sources believed to be reliable; however this update could include technical inaccuracies or typographical errors and Guttman Energy does not guarantee the accuracy, completeness or reliability of this update. FURTHERMORE, THIS UPDATE IS PROVIDED “AS IS,” WHERE IS, WITH ALL FAULTS AND WITHOUT ANY WARRANTY OR CONDITION OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY. GUTTMAN ENERGY ALSO SPECIFICALLY DISCLAIMS ALL EXPRESS AND IMPLIED WARRANTIES. YOU USE THIS UPDATE AT YOUR SOLE RISK. This update and any view or comment expressed herein are provided for informational purposes only and should not be interpreted in any way as recommendation or inducement to buy or sell products, commodity futures or options contracts.